VMA21 Antikörper
-
- Target Alle VMA21 Antikörper anzeigen
- VMA21 (Vacuolar H+-ATPase Homolog (VMA21))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VMA21 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human VMA21
- Isotyp
- IgG
-
anti-Vacuolar H+-ATPase Homolog (VMA21) (N-Term) antibody
VMA21 Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vacuolar H+-ATPase Homolog (VMA21) (N-Term) antibodyVMA21 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Schwein, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:150-1:500, IF 1: 50-1:200, ELISA 1:5000-1:240000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 2.6 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- VMA21 (Vacuolar H+-ATPase Homolog (VMA21))
- Andere Bezeichnung
- VMA21 (VMA21 Produkte)
- Synonyme
- MEAX antikoerper, XMEA antikoerper, ATP6H antikoerper, ATP6V0E antikoerper, M9.2 antikoerper, Vma21 antikoerper, Vma21p antikoerper, RGD1566155 antikoerper, 2610030H06Rik antikoerper, AI840175 antikoerper, VMA21, vacuolar ATPase assembly factor antikoerper, ATPase H+ transporting V0 subunit e1 antikoerper, VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) antikoerper, VMA21, vacuolar ATPase assembly factor L homeolog antikoerper, VMA21 antikoerper, ATP6V0E1 antikoerper, Vma21 antikoerper, vma21.L antikoerper
- Hintergrund
- This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase. Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. Associates with the V0 complex of the vacuolar ATPase (V-ATPase). MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion, affecting boys and sparing carrier females. Onset is in childhood, and patients exhibit weakness of the proximal muscles of the lower extremities, progressing slowly to involve other skeletal muscle groups over time.
- UniProt
- Q3ZAQ7
-
